# SK Bioscience to invest 150 billion won in vaccine factory expansion in Andong

SK Bioscience signed an MOU with Gyeongbuk Province and Andong City to invest about 150 billion won by 2024 to expand production facilities at its L House vaccine factory in Andong, South Korea, and establish new platform facilities for mRNA and next-generation viral vectors.

- Type: Expansion
- Announced: 2021-06-21
- Where: Andong, North Gyeongsang Province, South Korea
- Value: $133.0M (150.0B KRW)
- Starts operating: 2024
- Status: announced
- Products: vaccines
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [SK Bioscience](https://endata.com/companies/55971.md)

## Sources

- [english.makalukhabar.com](https://english.makalukhabar.com/sk-bioscience-to-invest-150-billion-won-in-vaccine-factory-expansion/), 2021-06-22: "SK Bioscience will invest about 150 billion won by 2024, and expand production facilities of L House which has the latest vaccine production facilities"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.